Literature DB >> 15207724

Nuclear structure-associated TIF2 recruits glucocorticoid receptor and its target DNA.

Hidesato Ogawa1, Ruth T Yu, Tokuko Haraguchi, Yasushi Hiraoka, Yoshihiro Nakatani, Ken-ichirou Morohashi, Kazuhiko Umesono.   

Abstract

Assembly of multi-protein complexes on promoter and enhancer elements is a prerequisite for onset of gene transcription. At the beginning of this process, transcription factors are thought to act as nucleating centers for complex formation through the binding of their target DNA sequences, and thereafter recruit coactivators. Here, we investigated this process of assembly by determining the distribution of the glucocorticoid receptor (GR) and its coactivator, TIF2. Both endogenously and ectopically expressed TIF2 were shown to form foci in the nucleus, and GR could be recruited to the TIF2 foci upon GR agonist but not antagonist treatment. Moreover, we show that the coactivators, p300 and PCAF, are also recruited to the TIF2 foci. The TIF2 foci could recruit GR carrying a microinjected GR responsive element. We propose that TIF2 provides a nuclear compartment that allows the assembly of multi-protein complexes required for GR-mediated gene activation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15207724     DOI: 10.1016/j.bbrc.2004.05.161

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Red1 promotes the elimination of meiosis-specific mRNAs in vegetatively growing fission yeast.

Authors:  Tomoyasu Sugiyama; Rie Sugioka-Sugiyama
Journal:  EMBO J       Date:  2011-02-11       Impact factor: 11.598

2.  A phosphomimetic mutation at threonine-57 abolishes transactivation activity and alters nuclear localization pattern of human pregnane x receptor.

Authors:  Satyanarayana R Pondugula; Cynthia Brimer-Cline; Jing Wu; Erin G Schuetz; Rakesh K Tyagi; Taosheng Chen
Journal:  Drug Metab Dispos       Date:  2009-01-26       Impact factor: 3.922

Review 3.  Glucocorticoid receptor control of transcription: precision and plasticity via allostery.

Authors:  Emily R Weikum; Matthew T Knuesel; Eric A Ortlund; Keith R Yamamoto
Journal:  Nat Rev Mol Cell Biol       Date:  2017-01-05       Impact factor: 94.444

4.  Insights on glucocorticoid receptor activity modulation through the binding of rigid steroids.

Authors:  Diego M Presman; Lautaro D Alvarez; Valeria Levi; Silvina Eduardo; Michelle A Digman; Marcelo A Martí; Adriana S Veleiro; Gerardo Burton; Adali Pecci
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

5.  Orphan nuclear receptor TR2, a mediator of preadipocyte proliferation, is differentially regulated by RA through exchange of coactivator PCAF with corepressor RIP140 on a platform molecule GRIP1.

Authors:  Pawan Gupta; Sung Wook Park; Mariya Farooqui; L-N Wei
Journal:  Nucleic Acids Res       Date:  2007-03-27       Impact factor: 16.971

6.  Red5 and three nuclear pore components are essential for efficient suppression of specific mRNAs during vegetative growth of fission yeast.

Authors:  Tomoyasu Sugiyama; Nobuyoshi Wanatabe; Eri Kitahata; Tokio Tani; Rie Sugioka-Sugiyama
Journal:  Nucleic Acids Res       Date:  2013-05-08       Impact factor: 16.971

7.  Mapping the Dynamics of the Glucocorticoid Receptor within the Nuclear Landscape.

Authors:  Martin Stortz; Diego M Presman; Luciana Bruno; Paolo Annibale; Maria V Dansey; Gerardo Burton; Enrico Gratton; Adali Pecci; Valeria Levi
Journal:  Sci Rep       Date:  2017-07-24       Impact factor: 4.379

8.  Rhn1, a nuclear protein, is required for suppression of meiotic mRNAs in mitotically dividing fission yeast.

Authors:  Tomoyasu Sugiyama; Rie Sugioka-Sugiyama; Kazumasa Hada; Ryusuke Niwa
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

9.  The Mediator subunit MED1/TRAP220 is required for optimal glucocorticoid receptor-mediated transcription activation.

Authors:  Wei Chen; Robert G Roeder
Journal:  Nucleic Acids Res       Date:  2007-09-07       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.